Wall Street Zen upgraded shares of Lantronix (NASDAQ:LTRX – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday morning. LTRX has been the topic of several other research reports. Needham & Company LLC raised their price objective on Lantronix from $5.50 to $7.50 and gave […]

Wall Street Zen upgraded shares of Information Services Group (NASDAQ:III – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday. III has been the subject of several other reports. Barrington Research upped their price objective on shares of Information Services Group from $5.50 to $7.00 […]

Wall Street Zen upgraded shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) from a sell rating to a hold rating in a research report released on Saturday. Several other research firms have also recently commented on DYN. Cowen restated a “buy” rating on shares of Dyne Therapeutics in a research report on Monday, December 8th. […]

Wall Street Zen upgraded shares of Bank of Marin Bancorp (NASDAQ:BMRC – Free Report) from a sell rating to a hold rating in a report issued on Saturday. A number of other equities research analysts have also recently commented on the company. Zacks Research upgraded Bank of Marin Bancorp from a “hold” rating to a […]

Wall Street Zen upgraded shares of Vita Coco (NASDAQ:COCO – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. Several other equities research analysts also recently commented on the company. Bank of America raised Vita Coco from a “neutral” rating to a “buy” rating and upped […]

Wall Street Zen upgraded shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Sunday morning. TBPH has been the subject of several other research reports. HC Wainwright lifted their price objective on Theravance Biopharma from $15.00 to $20.00 and gave […]

Wall Street Zen upgraded shares of Personalis (NASDAQ:PSNL – Free Report) from a sell rating to a hold rating in a research note released on Sunday morning. PSNL has been the subject of several other research reports. BTIG Research increased their price objective on Personalis from $11.00 to $12.00 and gave the company a “buy” […]

Wall Street Zen upgraded shares of FGI Industries (NASDAQ:FGI – Free Report) to a sell rating in a research report sent to investors on Saturday. A number of other equities analysts have also recently issued reports on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of FGI Industries in a report on […]

Wall Street Zen upgraded shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) from a sell rating to a hold rating in a research report released on Saturday. MAZE has been the topic of a number of other research reports. BTIG Research lifted their price target on shares of Maze Therapeutics from $30.00 to $37.00 and […]

Wall Street Zen upgraded shares of Freight Technologies (NASDAQ:FRGT – Free Report) to a hold rating in a report issued on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Freight Technologies in a report on Monday, December 8th. One investment analyst has rated the stock with a Sell rating, Based […]

Wall Street Zen upgraded shares of Kamada (NASDAQ:KMDA – Free Report) from a buy rating to a strong-buy rating in a report published on Saturday. A number of other research firms have also recently weighed in on KMDA. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Kamada in a report on Wednesday, October […]

Wall Street Zen upgraded shares of Sionna Therapeutics (NASDAQ:SION – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. A number of other equities research analysts have also recently commented on the stock. Raymond James Financial restated a “strong-buy” rating on shares of Sionna Therapeutics in […]

Wall Street Zen upgraded shares of Sionna Therapeutics (NASDAQ:SION – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. A number of other equities research analysts have also recently commented on the stock. Raymond James Financial restated a “strong-buy” rating on shares of Sionna Therapeutics in […]

Wall Street Zen upgraded shares of Sionna Therapeutics (NASDAQ:SION – Free Report) from a sell rating to a hold rating in a research report report published on Saturday. A number of other equities research analysts have also recently commented on the stock. Raymond James Financial restated a “strong-buy” rating on shares of Sionna Therapeutics in […]

Wall Street Zen upgraded shares of SU Group (NASDAQ:SUGP – Free Report) to a sell rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings reissued a “sell (d)” rating on shares of SU Group in a report on Wednesday, October 8th. One research analyst has rated the stock with a […]

Wall Street Zen upgraded shares of WAVE Life Sciences (NASDAQ:WVE – Free Report) from a sell rating to a hold rating in a report published on Saturday. Other analysts also recently issued reports about the company. Citigroup upped their price objective on WAVE Life Sciences from $16.00 to $30.00 and gave the company a “buy” […]

Wall Street Zen upgraded shares of Twin Disc (NASDAQ:TWIN – Free Report) from a hold rating to a buy rating in a report issued on Saturday. Several other brokerages have also issued reports on TWIN. Zacks Research upgraded shares of Twin Disc to a “hold” rating in a research report on Tuesday, December 9th. Weiss […]

Wall Street Zen upgraded shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX – Free Report) from a sell rating to a hold rating in a research report released on Saturday. EPRX has been the topic of a number of other research reports. Lifesci Capital upgraded shares of Eupraxia Pharmaceuticals to a “strong-buy” rating in a research report on […]

Wall Street Zen upgraded shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday. Several other brokerages also recently commented on HRMY. UBS Group cut their price target on shares of Harmony Biosciences from $50.00 to $43.00 and set a […]

Wall Street Zen upgraded shares of Microvast (NASDAQ:MVST – Free Report) from a buy rating to a strong-buy rating in a research report released on Saturday morning. A number of other analysts have also commented on MVST. Zacks Research lowered shares of Microvast from a “strong-buy” rating to a “hold” rating in a research note […]

Wall Street Zen upgraded shares of Jiuzi (NASDAQ:JZXN – Free Report) to a hold rating in a report published on Saturday. Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Jiuzi in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data […]

Wall Street Zen upgraded shares of OFS Credit (NASDAQ:OCCI – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. OFS Credit Price Performance OFS Credit stock opened at $4.56 on Friday. The firm has a 50-day moving average price of $4.89 and a two-hundred day moving […]

Wall Street Zen upgraded shares of Perma-Pipe International (NASDAQ:PPIH – Free Report) from a hold rating to a strong-buy rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings restated a “hold (c)” rating on shares of Perma-Pipe International in a research report on Monday, December 1st. One analyst has rated […]

Wall Street Zen upgraded shares of Domo (NASDAQ:DOMO – Free Report) from a hold rating to a buy rating in a research report released on Saturday morning. DOMO has been the subject of a number of other reports. Lake Street Capital decreased their price target on Domo from $16.00 to $13.00 and set a “hold” […]

Wall Street Zen upgraded shares of LKQ (NASDAQ:LKQ – Free Report) from a hold rating to a buy rating in a research report sent to investors on Saturday morning. A number of other research firms have also recently issued reports on LKQ. Weiss Ratings reiterated a “sell (d+)” rating on shares of LKQ in a […]

Wall Street Zen upgraded shares of Affirm (NASDAQ:AFRM – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. AFRM has been the subject of several other research reports. Bank of America boosted their target price on shares of Affirm from $94.00 to $98.00 and gave the company […]

Wall Street Zen upgraded shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) from a sell rating to a hold rating in a research note issued to investors on Saturday. Several other analysts also recently weighed in on the stock. Citigroup reiterated an “outperform” rating on shares of Taysha Gene Therapies in a research report […]

Wall Street Zen upgraded shares of Spero Therapeutics (NASDAQ:SPRO – Free Report) from a hold rating to a buy rating in a research note published on Sunday morning. A number of other analysts also recently weighed in on SPRO. Weiss Ratings restated a “sell (d-)” rating on shares of Spero Therapeutics in a report on […]

Wall Street Zen upgraded shares of Axcelis Technologies (NASDAQ:ACLS – Free Report) from a hold rating to a buy rating in a research report report published on Sunday. ACLS has been the subject of several other research reports. Benchmark raised shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a […]

Wall Street Zen upgraded shares of Structure Therapeutics (NASDAQ:GPCR – Free Report) from a sell rating to a hold rating in a report released on Saturday. GPCR has been the topic of a number of other reports. HC Wainwright reiterated a “buy” rating and issued a $60.00 target price on shares of Structure Therapeutics in […]

Wall Street Zen upgraded shares of Udemy (NASDAQ:UDMY – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Sunday. Several other equities research analysts have also recently issued reports on UDMY. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Udemy in a report on […]